Epigallocatechin gallate attenuates proliferation and oxidative stress in human vascular smooth muscle cells induced by interleukin-1β via heme oxygenase-1

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Liu, Po Len ^a   Liu, Jung Tung ^b,c   Kuo, Hsuan Fu ^d   Chong, Inn Wen ^a,d   Hsieh, Chong Chao ^d  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIGALLOCATECHIN GALLATE; HEME OXYGENASE 1; INTERLEUKIN 1BETA; TRANSCRIPTION FACTOR NRF2; ANTIOXIDANT; CATECHIN; NFE2L2 PROTEIN, HUMAN;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL PROTECTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; GROWTH INHIBITION; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; S PHASE CELL CYCLE CHECKPOINT; SMOOTH MUSCLE FIBER; TRANSCRIPTION INITIATION; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE CELL; ANALOGS AND DERIVATIVES; ATHEROSCLEROSIS; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECTS; ENZYME INDUCTION; METABOLISM; PATHOLOGY;

ANTIOXIDANTS; ATHEROSCLEROSIS; CATECHIN; CELL PROLIFERATION; CELLS, CULTURED; ENZYME INDUCTION; HEME OXYGENASE-1; HUMANS; INTERLEUKIN-1BETA; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS;

EID: 84908584027     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/523684     Document Type: Article

References (56)

1. F. M. Yatsu and M. Fisher, "Atherosclerosis: current concepts on pathogenesis and interventional therapies," Annals of Neurology, Vol. 26, no. 1, pp. 3-12, 1989.
2. M. Fisher, "Atherosclerosis: cellular aspects and potential interventions," Cerebrovascular and Brain Metabolism Reviews, Vol. 3, no. 2, pp. 114-133, 1991.
3. L. Liu, X. Xu, J. Li, X. Li, and W. Sheng, "Lentiviral-mediated shRNA silencing of PDE4D gene inhibits platelet-derived growth factor-induced proliferation and migration of rat aortic smooth muscle cells," Stroke Research and Treatment, Vol. 2011, Article ID 534257, 7pages, 2011.
4. J. Patel, K. M. Channon, and E. McNeill, "The downstream regulation of chemokine receptor signalling: implications for atherosclerosis," Mediators of Inflammation, Vol. 2013, Article ID 459520, 12pages, 2013.
5. O. Zimmermann, K. Li, and M. Zaczkiewicz, "C-reactive protein in human atherogenesis: facts and fction," Mediators of Inflammation, Vol. 2014, Article ID 561428, 6pages, 2014.
6. F. Strang and H. Schunkert, "C-reactive protein and coronary heart disease: all said - is not it?" Mediators of Inflammation, Vol. 2014, Article ID 757123, 7pages, 2014.
7. C.-P. Lin, Y.-H. Chen, H.-B. Leu et al., "Anti-inflammatory strategies for homocysteine-related cardiovascular disease," Frontiers in Bioscience, Vol. 14, no. 10, pp. 3836-3845, 2009.
8. C.-P. Lin, F.-Y. Lin, P.-H. Huang et al., "Endothelial progenitor cell dysfunction in cardiovascular diseases: role of reactive oxygen species and inflammation," BioMed Research International, Vol. 2013, Article ID 845037, 10pages, 2013.
9. G. Maiolino, G. Rossitto, P. Caielli, and et al, "The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts," Mediators of Inflammation, Vol. 2013, Article ID 714653, 13pages, 2013.
10. C. J. Liang, C. W. Lee, and H. C. Sung, "Ganoderma lucidum polysaccharides reduce lipopolysaccharide-induced interleu-kin-1 beta expression in cultured smooth muscle cells and in thoracic aortas in mice," Evidence-Based Complementary and Alternative Medicine, Vol. 2014, Article ID 305149, 13pages, 2014.
11. A. Bebes, F. Kovacs-Solyom, J. Prihoda et al., "Interleukin-1 receptors are differentially expressed in normal and psoriatic T cells," Mediators of Inflammation, Vol. 2014, Article ID 472625, 9pages, 2014.
12. S.-J. Lin, H.-T. Yen, Y.-H. Chen, H.-H. Ku, F.-Y. Lin, and Y.-L. Chen, "Expression of interleukin-1β and interleukin-1 receptor antagonist in oxLDL-treated human aortic smooth muscle cells and in the neointima of cholesterol-fed endothelia-denuded rabbits," Journal of Cellular Biochemistry, Vol. 88, no. 4, pp. 836-847, 2003.
13. O. Bədulescu, C. Bədescu, M. Ciocoiu, and M. Bədescu, "Inter-leukin-1-beta and dyslipidemic syndrome as major risk factors for thrombotic complications in type 2 diabetes mellitus," Mediators of Inflammation, Vol. 2013, Article ID 169420, 8pages, 2013.
14. A. Qamar and D. J. Rader, "Effect of interleukin 1β inhibition in cardiovascular disease," Current Opinion in Lipidology, Vol. 23, no. 6, pp. 548-553, 2012.
15. P. Bhardwaj and D. Khanna, "Green tea catechins: defensive role in cardiovascular disorders," Chinese Journal of Natural Medicines, Vol. 11, no. 4, pp. 345-353, 2013.
16. P. E. Szmitko and S. Verma, "Antiatherogenic potential of red wine: clinician update," The American Journal of Physiology - Heart and Circulatory Physiology, Vol. 288, no. 5, pp. H2023-H2030, 2005.
17. P. V. A. Babu, H. Si, and D. Liu, "Epigallocatechin gallate reduces vascular inflammation in db/db mice possibly through an NF-κB-mediated mechanism," Molecular Nutrition & Food Research, Vol. 56, no. 9, pp. 1424-1432, 2012.
18. P.-L. Liu, J.-R. Tsai, A. L. Charles et al., "Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-κB pathway and subsequently downregulating expression of matrix metallopro-teinases," Molecular Nutrition and Food Research, Vol. 54, no. 2, pp. S196-S204, 2010.
19. J.-R. Tsai, H.-M. Wang, P.-L. Liu et al., "High expression of heme oxygenase-1 is associated with tumor invasiveness and poor clinical outcome in non-small cell lung cancer patients," Cellular Oncology, Vol. 35, no. 6, pp. 461-471, 2012.
20. X.-H. Li, X. Gong, L. Zhang et al., "Protective effects of pol-ydatin on septic lung injury in mice via upregulation of HO-1," Mediators of Inflammation, Vol. 2013, Article ID 354087, 10pages, 2013.
21. A. Grochot-Przeczek, J. Dulak, and A. Jozkowicz, "Haem oxy-genase-1: non-canonical roles in physiology and pathology," Clinical Science, Vol. 122, no. 3, pp. 93-103, 2012.
22. B.-M. Choi, D.-W. Lim, J.-A. Lee, S. S. Gao, D. Y. Kwon, and B.-R. Kim, "Luteolin suppresses cisplatin-induced apoptosis in auditory cells: possible mediation through induction of heme oxygenase-1 expression," Journal of Medicinal Food, Vol. 11, no. 2, pp. 230-236, 2008.
23. F.-Y. Lin, Y.-H. Chen, Y.-W. Lin et al., "The role of human antigen R, an RNA-binding protein, in mediating the stabilization of toll-like receptor 4 mRNA induced by endotoxin: a novel mechanism involved in vascular inflammation," Arteriosclerosis, Trombosis, and Vascular Biology, Vol. 26, no. 12, pp. 2622-2629, 2006.
24. F.-Y. Lin, Y.-H. Chen, J.-S. Tasi et al., "Endotoxin induces tolllike receptor 4 expression in vascular smooth muscle cells via NADPH oxidase activation and mitogen-activated protein kinase signaling pathways," Arteriosclerosis, Trombosis, and Vascular Biology, Vol. 26, no. 12, pp. 2630-2637, 2006.
25. J.-W. Chen, Y.-H. Chen, and S.-J. Lin, "Long-term exposure to oxidized low-density lipoprotein enhances tumor necrosis factor-α;-stimulated endothelial adhesiveness of monocytes by activating superoxide generation and redox-sensitive pathways," Free Radical Biology & Medicine, Vol. 40, no. 5, pp. 817-826, 2006.
26. Y.-H. Chen, S.-J. Lin, H.-H. Ku et al., "Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF-α-treated human aortic endothelial cells," Journal of Cellular Biochemistry, Vol. 82, no. 3, pp. 512-521, 2001.
27. S.-J. Lin, T.-H. Yang, Y.-H. Chen et al., "Effects of Ginkgo biloba extract on the proliferation of vascular smooth muscle cells in vitro and on intimal thickening and interleukin-1 β expression after balloon injury in cholesterol-fed rabbits in vivo," Journal of Cellular Biochemistry, Vol. 85, no. 3, pp. 572-582, 2002.
28. P.-L. Liu, Y.-L. Chen, Y.-H. Chen, S.-J. Lin, and Y. R. Kou, "Wood smoke extract induces oxidative stress-mediated caspase-independent apoptosis in human lung endothelial cells: role of AIF and EndoG," The American Journal of Physiology: Lung Cellular and Molecular Physiology, Vol. 289, no. 5, pp. L739-L749, 2005.
29. J.-W. Chen, Y.-H. Chen, F.-Y. Lin, Y.-L. Chen, and S.-J. Lin, "Ginkgo biloba extract inhibits tumor necrosis factor-α-induced reactive oxygen species generation, transcription factor activation, and cell adhesion molecule expression in human aortic endothelial cells," Arteriosclerosis, Trombosis, and Vascular Biology, Vol. 23, no. 9, pp. 1559-1566, 2003.
30. Y.-H. Chen, F.-Y. Lin, P.-L. Liu et al., "Antioxidative and hepato-protective effects of magnolol on acetaminophen-induced liver damage in rats," Archives of Pharmacal Research, Vol. 32, no. 2, pp. 221-228, 2009.
31. Y. Zheng, A. Morris, M. Sunkara, J. Layne, M. Toborek, and B. Hennig, "Epigallocatechin-gallate stimulates NF-E2-related factor and heme oxygenase-1 via caveolin-1 displacement," Journal of Nutritional Biochemistry, Vol. 23, no. 2, pp. 163-168, 2012.
32. T. Li, Y.-H. Chen, T.-J. Liu et al., "Using DNA microarray to identify Sp1 as a transcriptional regulatory element of insulin-like growth factor 1 in cardiac muscle cells," Circulation Research, Vol. 93, no. 12, pp. 1202-1209, 2003.
33. A. T. Dinkova-Kostova, W. D. Holtzclaw, R. N. Cole et al., "Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants," Proceedings of the National Academy of Sciences of the United States of America, Vol. 99, no. 18, pp. 11908-11913, 2002.
34. R. M. Starke, N. Chalouhi, M. S. Ali et al., "The role of oxidative stress in cerebral aneurysm formation and rupture," Current Neurovascular Research, Vol. 10, no. 3, pp. 247-255, 2013.
35. R. Johnson, S. Bryant, and A. L. Huntley, "Green tea and green tea catechin extracts: an overview of the clinical evidence," Maturitas, Vol. 73, no. 4, pp. 280-287, 2012.
36. N. Khan and H. Mukhtar, "Tea and health: studies in humans," Current Pharmaceutical Design, Vol. 19, no. 34, pp. 6141-6147, 2013.
37. C. C. Wu, M. C. Hsu, C. W. Hsieh, J. B. Lin, P. H. Lai, and B. S. Wung, "Upregulation of heme oxygenase-1 by Epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase/Akt and ERK pathways," Life Sciences, Vol. 78, no. 25, pp. 2889-2897, 2006.
38. Y. Zheng, M. Toborek, and B. Hennig, "Epigallocatechin gallate-mediated protection against tumor necrosis factor-α-induced monocyte chemoattractant protein-1 expression is heme oxygenase-1 dependent," Metabolism: Clinical and Experimental, Vol. 59, no. 10, pp. 1528-1535, 2010.
39. P. Pullikotil, H. Chen, R. Muniyappa et al., "Epigallocatechin gallate induces expression of heme oxygenase-1 in endothelial cells via p38 MAPK and Nrf-2 that suppresses proinflammatory actions of TNF-α," Journal of Nutritional Biochemistry, Vol. 23, no. 9, pp. 1134-1145, 2012.
40. H.-K. Na, E.-H. Kim, J.-H. Jung, H.-H. Lee, J.-W. Hyun, and Y.-J. Surh, "(-)-Epigallocatechin gallate induces Nrf2-mediated antioxidant enzyme expression via activation of PI3K and ERK in human mammary epithelial cells," Archives of Biochemistry and Biophysics, Vol. 476, no. 2, pp. 171-177, 2008.
41. L. Romeo, M. Intrieri, V. D'Agata et al., "The major green tea polyphenol, (-)-epigallocatechin-3-gallate, induces heme oxy-genase in rat neurons and acts as an effective neuroprotective agent against oxidative stress," Journal of the American College of Nutrition, Vol. 28, pp. 492S-499S, 2009.
42. K. Sahin, M. Tuzcu, H. Gencoglu et al., "Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats," Life Sciences, Vol. 87, no. 7-8, pp. 240-245, 2010.
43. Y. Kakuta, M. Okumi, Y. Isaka et al., "Epigallocatechin-3-gallate protects kidneys from ischemia reperfusion injury by HO-1 upregulation and inhibition of macrophage infiltration," Transplant International, Vol. 24, no. 5, pp. 514-522, 2011.
44. M.-H. Kweon, V. M. Adhami, J.-S. Lee, and H. Mukhtar, "Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate," The Journal of Biological Chemistry, Vol. 281, no. 44, pp. 33761-33772, 2006.
45. I.-T. Lee, C.-C. Lin, C.-Y. Lee, P.-W. Hsieh, and C.-M. Yang, "Protective effects of (-)-epigallocatechin-3-gallate against TNF-α-induced lung inflammation via ROS-dependent ICAM-1 inhibition," Journal of Nutritional Biochemistry, Vol. 24, no. 1, pp. 124-136, 2013.
46. H. You, L. Wei, W. L. Sun et al., "The green tea extract epigallocatechin-3-gallate inhibits irradiation-induced pulmonary fibrosis in adult rats," International Journal of Molecular Medicine, Vol. 34, no. 1, pp. 92-102, 2014.
47. M. Zhang, B. H. Zhang, L. Chen, and W. An, "Overexpression of heme oxygenase-1 protects smooth muscle cells against oxidative injury and inhibits cell proliferation," Cell Research, Vol. 12, no. 2, pp. 123-132, 2002.
48. F. Jiang, R. Jiang, X. Zhu, X. Zhang, and Z. Zhan, "Genipin Inhibits TNF-α-Induced Vascular Smooth Muscle Cell Proliferation and Migration via Induction of HO-1," PLoS ONE, Vol. 8, no. 8, Article ID e74826, 2013.
49. R. R. Campos, "Oxidative stress in the brain and arterial hypertension," Hypertension Research, Vol. 32, no. 12, pp. 1047-1048, 2009.
50. J. E. Kim, Y. J. Kang, K. Y. Lee, and H. C. Choi, "Isoproterenol inhibits angiotensin II-stimulated proliferation and reactive oxygen species production in vascular smooth muscle cells through heme oxygenase-1," Biological and Pharmaceutical Bulletin, Vol. 32, no. 6, pp. 1047-1052, 2009.
51. R. M. Ogborne, S. A. Rushworth, and M. A. O'Connell, "Epi-gallocatechin activates haem oxygenase-1 expression via protein kinase Cδ and Nrf2," Biochemical and Biophysical Research Communications, Vol. 373, no. 4, pp. 584-588, 2008.
52. C. J. Sherr, "Cancer cell cycles," Science, Vol. 274, no. 5293, pp. 1672-1677, 1996.
53. Y.-H. Chen, S.-J. Lin, Y.-L. Chen, P.-L. Liu, and J.-W. Chen, "Anti-inflammatory effects of different drugs/agents with antioxidant property on endothelial expression of adhesion molecules," Cardiovascular and Hematological Disorders - Drug Targets, Vol. 6, no. 4, pp. 279-304, 2006.
54. A. Fortuño, G. San Jos̈e, M. U. Moreno, J. Díez, and G. Zalba, "Oxidative stress and vascular remodelling," Experimental Physiology, Vol. 90, no. 4, pp. 457-462, 2005.
55. E. O. Farombi and Y.-J. Surh, "Heme oxygenase-1 as a potential therapeutic target for hepatoprotection," Journal of Biochemistry and Molecular Biology, Vol. 39, no. 5, pp. 479-491, 2006.
56. H. S. Marinho, C. Real, L. Cyrne, H. Soares, and F. Antunes, "Hydrogen peroxide sensing, signaling and regulation of transcription factors," Redox Biology, Vol. 2, pp. 535-562, 2014.